Kimberly Lenz, PharmD
State Medicaid programs have been winning some key battles in the fight against soaring drug prices, including a $95 million rebate that Massachusetts wrested from a manufacturer under a negotiated value-based deal, and $300 million in rebates resulting from similar efforts in New York State. But on a national level, many challenges remain, including the huge cost of breakthrough therapies, stakeholders reported at the AMCP Nexus 2020 Virtual meeting.
In the